Interest Rates Rising: Is it a Bad Idea to Buy Growth Stocks Today?

Interest Rates Rising: Is it a Bad Idea to Buy Growth Stocks Today?

Growth stocks are still being whipsawed in the market right now. Capping your positions in growth stocks with earnings would be wise.

The post Interest Rates Rising: Is it a Bad Idea to Buy Growth Stocks Today? appeared first on The Motley Fool Canada.

Year to date, stocks, particular growth stocks have sold off significantly partly from higher borrowing cost from rising interest rates. Is it a bad idea to buy growth stocks today? It depends. And here’s why.
Growth stocks encompass a wide range of stocks. Among them are tech stocks like Docebo (TSX:DCBO), which hasn’t turned a profit yet, and TELUS International (TSX:TIXT), which has earnings. Rationally, it’s safer to consider investing in the latter over the former because the latter is making a profit and the former is losing money.
What do rising interest rates have to do with growth stocks?
Higher borrowing costs
Rising interest rates increase the borrowing costs for businesses and consumers. So, businesses and consumers become more careful about their spending. Businesses are more cautious about investing in growth projects, which become less attractive because of higher costs and, therefore, lower expected returns. Ultimately, rising interest rates lead to slower economic growth.
It’s a good thing Docebo has little long-term debt on its balance sheet. Its debt-to-equity (D/E) ratio is about 44% with almost 92% of its debt being current liabilities that are due within the year, primarily consisting of deferred revenues (products and services it needs to deliver) and accounts payable, which make up 60% and 29% of its total debt, respectively. Its long-term debt-to-capital ratio is only about 1%. So, it pays very little interest expense.
As a lower-risk investment that’s profitable, TELUS International is accordingly able to sustain a higher D/E ratio of 1.07 times. Its long-term debt-to-capital ratio is also higher at about 25%. That said, its interest expense is easily manageable with its earnings and cash flow.
Stock price valuation compression
Docebo was growing its revenues at a high pace before the central bank started raising interest rates aggressively to counter high inflation. The revenue growth is no longer enough to maintain its high price-to-sales multiple (P/S).
It also benefited massively during the pandemic with revenue growth of 52% in 2020. Its P/S was 42.9 in 2020. It is estimated to be about 7.8 times this year with revenue growth of approximately 30-40%. In any case, the valuation compression will make it a bad idea to raise capital in the form of equity offerings on the stock market. Because of quantitative tightening, capital raising on the financial markets has seriously shrunk.
Even though TELUS International has been profitable, it wasn’t immune from the stock price valuation compression from rising interest rates. In 2021, the growth stock traded as high as +40 times earnings. At $25 and change per share, it trades at about 16.3 times earnings, which is much more reasonable for its expected earnings-per-share growth rate of about 11-13% per year over the next few years.
The Foolish investor takeaway
Rising interest rates aren’t all bad. Because of it, investors can purchase growth stocks at lower valuations for a cheaper price.
It’s okay to buy some growth stocks if you limit their percentage in your portfolio. Proper allocation of growth stocks and portfolio diversification can help mitigate risk. It also makes a difference what type of growth stocks you buy. Sticking with ones with earnings can help you sleep better at night and make better risk-adjusted returns.
Between Docebo and TELUS International, the latter would be a better buy today, despite both being whipsawed by higher interest rates.
The post Interest Rates Rising: Is it a Bad Idea to Buy Growth Stocks Today? appeared first on The Motley Fool Canada.

Should You Invest $1,000 In Docebo?

Before you consider Docebo, you’ll want to hear this.
Our market-beating analyst team just revealed what they believe are the 5 best stocks for investors to buy in November 2022 … and Docebo wasn’t on the list.
The online investing service they’ve run for nearly a decade, Motley Fool Stock Advisor Canada, is beating the TSX by 15 percentage points. And right now, they think there are 5 stocks that are better buys.
See the 5 Stocks
* Returns as of 11/4/22

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];[property] = defaultValue;
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);

More reading

3 Bargain Stocks to Buy Today and Hold for the Next 5 Years
Better Buy: Docebo Stock vs. Thinkific Labs
3 Growth Stocks Down 25% to 75% I’d Buy Today
3 Best Artificial Intelligence Stocks to Buy in November 2022
TSX Today: What to Watch for in Stocks on Monday, November 7

Fool contributor Kay Ng has no position in any of the stocks mentioned. The Motley Fool recommends Docebo Inc. and TELUS International (Cda) Inc. The Motley Fool has a disclosure policy.

Powered by WPeMatico

Canadian Stock Trader

Stock Trading Gold Stocks Marijuana Stocks Oil Stocks Penny Stocks Tech Stocks Business News Day Trading Canadian Stock Trader TSE TSXV American Stocks Canadian Stocks Canadian Stock Trader Canadian Stock Market All the latest Business News. Special coverage of Gold Stocks, Marijuana Stocks, Oil Stocks, Option Trading, Penny Stocks,Stock Trading Technics and Tech Stocks….